Reflex sympathetic dystrophy treated with gabapentin

Archives of Physical Medicine and Rehabilitation

Volumn 78, Issue 1, 1997, Pages 98-105

  Mellick, Gary A ^a   Mellick, Larry B ^b  

^a American Pain Specialists Inc   (United States)

^b LOMA LINDA UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; ANALGESIC AGENT; ANESTHETIC AGENT; ANTICONVULSIVE AGENT; BACLOFEN; CYPROHEPTADINE; DIPHENHYDRAMINE; DOSEPAK; GABAPENTIN; IBUPROFEN; METHYLPREDNISOLONE; NONSTEROID ANTIINFLAMMATORY AGENT; NORTRIPTYLINE; TRACER; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BONE SCINTISCANNING; CLINICAL ARTICLE; DIARRHEA; FEMALE; GRAND MAL SEIZURE; HEADACHE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; JOINT CHARACTERISTICS AND FUNCTIONS; LEG CRAMP; NERVE BLOCK; NEUROLOGIC EXAMINATION; OCCUPATIONAL THERAPY; ORAL DRUG ADMINISTRATION; PAIN; PHYSIOTHERAPY; STELLATE GANGLION BLOCK; SYMPATHETIC BLOCKING; SYMPATHETIC DYSTROPHY; TRANSCUTANEOUS NERVE STIMULATION; VERTIGO;

EID: 0031030978     PISSN: 00039993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0003-9993(97)90020-4     Document Type: Article

References (79)

1. Waldman SD, Waldman KA. Reflex sympathetic dystrophy. Int Med Mag 1990;11:62-8.
2. Fields HL, Pain. New York: McGraw-Hill, 1988.
3. Schwartzman RJ, McLelan RL. Reflex sympathetic dystrophy: a review. Arch Neurol 1987;44:555-61.
4. Horton P, Gerster JC. Reflex sympathetic dystrophy syndrome and barbiturates. A study of 25 cases treated with barbiturates compared with 124 cases treated without barbiturates. Clin Rheumatol 1984; 3:493-500.
5. Taylor L, Payne R, Young D, Stern R, Posner J. Phenobarbital rheumatism in primary brain tumor patients. Ann Neurol 1987;22: 117-8.
6. Michaels RM, Sorber JA. Reflex sympathetic dystrophy as a probable paraneoplastic syndrome: case report and literature review. Arthritis Rheum 1984;27:1183-5.
7. Paie Q, Les oeuvres d'Ambroise Paré (histoire de defunct), Roy Charles IX, Tenth Book. Paris: Gabriel Buon, 1598;41:401.
8. Denmark A. An example of symptoms resembling tic douleureus produced by a wound in the radial nerve. Royal Med Chir Trans 1813;4:48-52.
9. Hamilton J. On some effects resulting from wounds of nerves. Dublin J Med Sc 1838;13:38-55.
10. Mitchell SW, Morehouse GR, Keen WW. Gunshot wounds and othe injuries of nerves. Philadelphia: JB Lippincott, 1864.
11. Rizzi R, Viscentin M, Maxetti G. Reflex sympathetic dystrophy. In: Benedetti C, Chapman CR, Monica G, editors. Advances in pain research, vol. 7. New York: Raven Press, 1984:451-64.
12. Goa KL, Sorkin EM. Gabapentin: a review of its pharmacological properties and clinical potential in epilepsy. Drugs 1993;46:409-27.
13. Andrew J, Chadwick D, Bates D, Cartlidge N, Boddie G, Bolel P, et al. Gabapentin in partial epilepsy. Lancet 1990;335:1114-7.
14. Ojemann LM, Wilensky AJ, Temkin NR, Chmelir T, Ricker BA, Wallace J. Long-term treatment for partial epilepsy. Epilepsy Res 1992;13:159-65.
15. Neurontin® (Gabapentin Capsules). Product monograph. Morris Plains (NJ): Parke-Davis, 1994.
16. Foot M, Wallace J. Gabapentin. Epilepsy Res 1991;3 Suppl:109-14.
17. 3H]-gabapentin to a novel site in rat brain: autoradiographic studies. Eur J Pharmacol 1993;244:303-9.
18. Hooshmand H. Chronic pain: reflex sympathetic dystrophy prevention and management. Boca Raton (FL): CRC Press, 1993.
19. Kondo T, Fromm GH, Schmidt B, Comparison of gabapentin with other antiepileptic and GABAergic drugs. Epilepsy Res 1991;8: 226-31.
20. Loscher W, Honeck D, Taylor CR. Gabapentin increases aminooxyacetic acid-induced GABA accumulation in several regions in rat brain. Neurosci Lett 1991;128:150-4.
21. Bartoszyk GD, Meyerson N, Reimann W, Satzinger G, von Hodenberg A. Gebapentin. In: Meldrum BS, Porter RJ, editors. New anticonvulant drugs. London: John Libby & Co., 1986.
22. Lewis BD, Renaud B, Buda M, Pujol JF. Time-course variation in tyrosine hydroxylase activity in the rat locus coeruleus after electrolytic destruction of the nucleus raphe dorsalis or raphe centralis. Brain Res 1976;108:339-44.
23. Crespi F, Buda M, McRae-Dequeurce A, Pujol JF. Alteration of tyrosine hydroxylase activity in the locus coeruleus after administration of p-chlorophenylalanine. Brain Res 1980;191:501-9.
24. Reader TA, Jasper HH. Interaction between monoamines and other transmiters in cerebral cortex. In: Descarries L, Reader TR, Jasper HH, editors. Monoamine innervation of cerebral cortex. New York: Liss, 1984:195-225.
25. McRae-Degueurce A, Dennis T, Leger L, Scatton B. Regulation of neuronal activity in the rat locus coeruleus by serotonergic afferents. Physiol Psychol 1985;344:158-61.
26. Rappaport A, Sturtz F, Guicheney P. Regulation of central alpha adrenoceptors by serotonergic denervation. Brain Res 1985;344: 158-61.
27. Leger L, Descarries L. Serotonin nerve terminals in the locus coeruleus of adult rat. A radiolautographic study. Brain Res 1978; 145: 1-13.
28. Nygren LG, Olson L. A new major projection from the locus coeruleus: the main source of noradrenergic nerve terminals in the ventral and dorsal columns of the spinal cord. Brain Res 1977; 132:85-93.
29. Carpenter MB, Medulla. In: Tracy MT, Vaughn VM, editors. Core text of neuroanatomy. 3rd ed. Baltimore: Williams and Wilkins, 1985:102-32.
30. Basbaum AI, Clanton CH, Fields HL. Three bulbospinal pathways from the rostral medulla of the cat: an autoradiographic study of pain modulating systems. J Comp Neurol 1978; 178:209-24.
31. Basbaum AI, Clanton CH, Fields HL. Opiate and stimulus-produced analgesia: functional anatomy of medullospinal pathways. Proc Natl Acad Sci U S A 1976;73:4685-8.
32. Basbaum AI, Fields HL. Endogenous pain control systems: brainstem spinal pathways and endorphin circuitry. Annu Rev Neurosci 1984;7:309-38.
33. Besson JM, Chaoch A. Peripheral and spinal mechanisms of nociception. Physiol Rev 1987;67:67-186.
34. Basbaum AI, Clanton CH, Fields HL. Three bulbospinal pathways from the rostral medulla of the cat: an autoradiographic study of pain modulating systems. J Comp Neurol 1978; 178:209-24.
35. Holstege G, Kuypers HGJM. The anatomy of brainstem pathways to the spinal cord in cat. A labeled amino acid tracing study. Prog Brain Res 1982;57:45-75.
36. Mason P, Fields HL. Axonal trajectories and terminations of on-and off-cells in the lower brainstem of the cat. J Comp Neurol 1989;288:185-207.
37. Basbaum AI, Ralston HJ, III. Bulbospinal projections in the primate: a light and electron microscopic study of a pain modulating system. J Comp Neurol 1986;250:311-23.
38. Basbaum AI, Fields HL. The origin of descending pathways in the dorsolateral funiculus of the spinal cord of the cat and rat: further studies on the anatomy of pain modulation. J Comp Neurol 1979; 187:513-32.
39. Ruda MA, Allen B, Gobel S. Ultrastructural analysis of medial brainstem afferents to the superficial dorsal horn. Brain Res 1981; 205:175-80.
40. Light AR, Perl ER. Reexamination of dorsal root projection to the spinal dorsal horn including observations on the differential termination of coarse and fine fibers. J Comp Neurol 1979; 186: 117-32.
41. Light AR, Perl ER. Spinal termination of functionally identified primary afferent neurons with slowly conducting myelinated fibers. J Comp Neurol 1979; 186:133-50.
42. Cervero F, Iggo A. The substantia gelatinosa of the spinal cord. A critical review. Brain 1980; 103:717-72.
43. Fields HL, Basbaum AI. Brainstem control of spinal pain-transmission neurons. Annu Res Physiol 1978;40:217-48.
44. Dubner R, Bennett GJ. Spinal and trigeminal mechanisms of nociception. Annu Res Neurosci 1983;6:381-418.
45. Bowker RM, Westlund KN, Coulter JD. Origins of serotonergic projectionsy to the spinal cord in rat: an immunocytochemical-retrograde transport study. Brain Res 1981;226:187-99.
46. Bowker RM, Dilts RP. Distribution of mu opioid receptors in the nucleus raphe magnus and nucleus gigantocellularis: a quantitative autoradiographic study. Neurosci Lett 1988; 88:247-52.
47. Lovick TA, Robinson JP. Substance P-immunoreactive and serotonin-containing neurones in the ventral brainstem of the cat. Neurosci Lett 1983;36:223-8.
48. Skagerberg G, Bjorklund A. Topographic principles in the spinal projections of serotonergic and non-serotonergic brainstem neurons in the rat, Neuroscience 1985; 15:445-80.
49. Dahlstrom A, Fuxe K. Evidence for the existence of monamine neurons in the central nervous system. IL Experimental demonstration of monamines in the cell bodies of brain stem neurons. Acta Physiol Scand 1964;62 Suppl 232:1-55.
50. Oliveras JL, Bourgoin S, Hery F, Besson JM, Hamon M. The topographical distribution of serotonergic terminals in the spinal cord of the cat: biochemical mapping by the combined use of microdissection and microassay procedures. Brain Res 1977;138:393-406.
51. Llewelyn MB, Azami J, Roberts MHT. Effects of 5-hydroxytryptamine applied into nucleus raphe mangus on nociceptive thresholds and neuronal firing rate. Brain Res 1983;258:59-68.
52. Llewelyn MB, Azami J, Roberts MHT. The effect of modification of 5-hydroxytryptamine function in nucleus raphe magnus on nociceptive threshold. Brain Res 1984;306:165-70.
53. Inase M, Nakahama H, Otsjik T, Fang J. Analgesic effects of serotonin microinjection into nucleus raphe magnus and nucleus raphe dorsalis evaluated by the monosodium urate (MSU) tonic pain model in the rat. Brain Res 1987;426:205-11.
54. Aimone LD, Gebhart GF. Stimulation-produced spinal inhibition from the midbrain in the rat is mediated by an excitatory amino acid neurotransmitter in the medial medulla. J Neurosci 1986;6: 1803-13.
55. Fuxe K. Evidence for the existence of monoamine neurons in the central nervous system. Acta Physiol Scand Suppl 1965;247:37-84.
56. Takagi H, Yamamoto K, Shiosaka S, Senba E, Takatsuki K, Inagaki S, et al. Morphological study of noradrenaline innervation in the caudal raphe nuclei with special reference to fine structure. J Comp Neurol 1981;203:15-22.
57. 2 receptors: light microscopic and autoradiographic localization. Proc Natl Acad Sci U S A 1980;77:1696-700.
58. 2 agonist binding sites in the rat and human central nervous system: analysis of some functional, anatomic correlates of the pharmacologic effects of clonidine and related adrenergic agents. Brain Res Rev 1984;7:69-101.
59. Heinricher MM, Haws CM, Fields HL. Opposing actions of norepinephrine and clonidine on single pain modulating neurons in rostral ventromedial medulla. In: Dubner R, Gebhart GF, Bond MR, editors. Proceedings of the 5th World Congress on Pain. Amsterdam: Elsevier, 1988;590-4.
60. Fields HL, Heinricher MM, Mason P. Neurotransmitters in nociceptive modulatory circuits. Annu Rev Neurosci 1991;14:219-45.
61. Levine JD, Fields HL, Basbaum AI. Peptides and primary afferent nociceptor. J Neurosci 1993; 13:2273-86.
62. Melzack R. Phantom limb pain: implications for treatment of pathological pain. Anesthesiology 1971;35:409.
63. Livingston WK. Pain mechanisms: a physiologic interpretation of causalgia and its related states. New York: Macmillan, 1943.
64. Ochoa J. The newly recognized painful ABC Syndrome! Thermographic aspects. Thermology 1986;2:65.
65. Rao ML, Clarenbach P, Vahlensieck M, Kratzschmar S. Gabapentin augments whole blood serotonin in healthy young men. J Neural Transm 1988;73:129-34.
66. Jouvet M. Biogenic amines and the states of sleep. Science 1969; 163:32-41.
67. Melzack R, Wall PD. Pain mechanisms: a new theory. Science 1965; 150:971-9.
68. Besson JMR. Supraspinal modulation of the supraspinal transmission of pain. In: Kosterlitz HW, Terenius LY, editors. Pain and society. Weinheim, Germany: Verlag Chemie, 1980:161-82.
69. Sicuteri F, Anselmi B, Del Bianco P. 5-Hydroxytryptamine supersensitivity as a new theory of headache and central pain: a clinical pharmacological approach with p-chlorophenylalanine. Psychoparmacologia (Berl) 1973;29:347-56.
70. Tenen SS. The effects of p-chlorophenylalanine, a serotonin depletor, on avoidance, acquisition, pain sensitivity and related behaviour in the rat. Psychopharmacologia (Berl) 1967;10:204-19.
71. Sternbach RA, editor. Psychology of pain. New York: Raven Press, 1986.
72. Mersky H. Development of a universal language of pain syndromes. Plenary session address, Third World Congress, International Association for the Study of Pain. In: Bonica JJ, et al, editors. Advances in pain research and therapy, vol 5. New York: Raven Press, 1983: 37-52.
73. Sternbach RA. Pain patients: traits and treatment. New York: Academic Press, 1974.
74. Sternbach RA. Acute versus chronic pain. In: Wall PD, Melzack R, editors. Textbook of pain. London: Churchill Livingstone, 1984: 173-7.
75. Sternbach RA, Janowsky DS, Huey LY, Segal DS. Effects of altering brain serotonin activity on human chronic pain. In: Bonica JJ, Albe-Fesard DL, editors. Advances in pain research and therapy, vol 1. New York: Raven Press, 1976:601-6.
76. Terenius LY. Biochemical assessment of chronic pain. In: Kosterlitz HW, Terenius LY, editors. Basel: Verlag Chemie, 1980;355-64.
77. Mellick G, Mellick L. Successful treatment of restless legs syndrome with gabapentin (Neurontin) [abstract]. Neurology 1995;45: 285-6.
78. Mellick G, Mellick L. Management of restless legs syndrome with gabapentin (Neurontin). Sleep 1996;19:224-6.
79. Mellick GA, Seng M. The use of gabapentin in the treatment of reflex sympathetic dystrophy and a phobic disorder. AJPM 1995; 5:7-9.